Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Have You Heard

Wednesday, 04 January 2017

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending extension of the label for all metformin-containing products to included patients with stable moderate renal failure (chronic kidney disease stage 3).

Category: Have You Heard
Topics covered:
Wednesday, 04 January 2017

Dapagliflozin is now recommended by NICE as part of triple therapy with metformin and a sulfonylurea when two drugs for type 2 diabetes are not providing glycaemic control.

Category: Have You Heard
Topics covered:
Thursday, 20 October 2016

A new document from Public Health England (PHE) highlights the ongoing impact of cardiovascular disease (CVD), and provides an overview of PHEs work in CVD.

Category: Have You Heard
Topics covered:
Thursday, 20 October 2016

In a new Clinical Guideline on multimorbidity, NICE calls for a tailored approach to care when treating people with two or more long-term health conditions. The guideline sets out ways to put patients with complex health issues at the heart of decisions about their care, including how to decide between different medicines and treatments.

Category: Have You Heard
Thursday, 20 October 2016
Diabetes UK has developed a new resource guide designed to encourage healthcare professionals to use root cause analysis (RCA) to help reduce the number of unnecessary diabetes-related amputations. The new guide provides practical, step-by-step information on how to complete RCA. It includes who to involve, how to gather the right data, and techniques to help identify root causes.
Category: Have You Heard
Topics covered:
Thursday, 08 September 2016

NICE has published a new diabetes quality standard for adults featuring seven new and updated statements covering type 2 diabetes prevention, structured education programmes, care and treatment, and prevention and management of foot problems. The new quality standard updates the 2011 version.

Category: Have You Heard
Topics covered:
Thursday, 08 September 2016

The British Heart Foundation has launched the Miles Frost Fund to establish a UK-wide cascade testing service for families at risk of hypertrophic cardiomyopathy (HCM). The fund has been established in memory of Sir David Frost’s son Miles who died suddenly from an undiagnosed heart condition in 2015.

Category: Have You Heard
Thursday, 08 September 2016

The American Heart Association has published a scientific statement providing prescribers with a list of drugs that can cause or worsen heart failure. Heart failure patients are usually taking medications for multiple medical conditions with resulting risk for drug-drug or drug-condition interactions.

Category: Have You Heard
Topics covered:

Article search and filter